Search
Search Results
##search.searchResults.foundPlural##
-
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1487PDF: 827HTML: 438 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2697PDF: 898HTML: 501 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
2013PDF: 878HTML: 3705 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4742PDF: 1607HTML: 8565 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
3405PDF: 1152HTML: 358Suppl. Files: 548 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2749PDF: 1850HTML: 744 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1641PDF: 1046HTML: 461 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1546PDF: 794HTML: 1206Untitled: 239Untitled: 217Untitled: 204Untitled: 210Untitled: 222 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1355PDF: 798HTML: 1282 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2210PDF: 1136HTML: 15751COVER LETTER: 272 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
651PDF: 323HTML: 166 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4504PDF: 1634HTML: 497 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1691PDF: 873HTML: 1552Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 240 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2266PDF: 891HTML: 1249 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3951PDF: 1408HTML: 2204Fig.1: 309Fig. 2: 295 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
808PDF: 516HTML: 6298 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
909PDF: 976PDF Supp. Files: 121HTML: 274
1 - 35 of 35 items







